Income Taxes (Tables)
|
12 Months Ended |
Dec. 31, 2024 |
| Income Tax Disclosure [Abstract] |
|
| Schedule of Income (Loss) Before Provision for Income Taxes |
The components of the Company’s income (loss) before provision for income taxes are as follows (in thousands): | | | | | | | | | | | | | | | | | | | Year Ended December 31, | | 2024 | | 2023 | | 2022 | | U.S. | $ | 113,045 | | | $ | 136,498 | | | $ | 34,344 | | | Foreign | (363,621) | | | 40,659 | | | (39,296) | | | Income (loss) before provision for income taxes | $ | (250,576) | | | $ | 177,157 | | | $ | (4,952) | |
|
| Schedule of Components of Income Tax Expense (benefit) |
The provision for income taxes charged to operations consists of the following (in thousands): | | | | | | | | | | | | | | | | | | | Year Ended December 31, | | 2024 | | 2023 | | 2022 | | Current expense (benefit): | | | | | | | Federal | $ | 21,686 | | | $ | 26,592 | | | $ | 12,826 | | | State | 2,707 | | | 5,678 | | | 1,630 | | | Foreign | 3,075 | | | 16,509 | | | 7,725 | | | 27,468 | | | 48,779 | | | 22,181 | | | Deferred expense (benefit): | | | | | | | Federal | (1,361) | | | 942 | | | (6,160) | | | State | (406) | | | (327) | | | (960) | | | Foreign | (35,883) | | | (9,477) | | | (24,445) | | | (37,650) | | | (8,862) | | | (31,565) | | | Total income tax expense (benefit) | $ | (10,182) | | | $ | 39,917 | | | $ | (9,384) | |
|
| Schedule of Deferred Tax Assets and Liabilities |
Significant components of the Company’s deferred tax assets and liabilities were as follows (in thousands): | | | | | | | | | | | | | December 31, | | 2024 | | 2023 | | Deferred tax assets: | | | | | Bad debts | $ | 143 | | | $ | 164 | | | Inventories | 5,439 | | | 3,528 | | | Accrued warranties | 4,753 | | | 4,336 | | | Accrued compensation | 496 | | | 569 | | | Net operating loss | 4,247 | | | 2,181 | | | Equity-based compensation | 2,769 | | | 3,222 | | | Lease liabilities | 4,982 | | | 5,794 | | | Premium on capped call | 7,777 | | | 9,376 | | | Interest expense carryforward | 80 | | | 3,411 | | | Capitalized research and development expenses | 6,405 | | | 2,000 | | | Other | 5,164 | | | 4,580 | | | Deferred tax assets | 42,255 | | | 39,161 | | | Valuation allowance | (11,181) | | | (2,360) | | | Deferred tax assets, net | 31,074 | | | 36,801 | | | Deferred tax liabilities: | | | | | Property, plant, and equipment | (2,349) | | | (2,825) | | | Intangible assets | (28,450) | | | (79,913) | | | ROU assets | (3,919) | | | (5,051) | | | Deferred tax liabilities | (34,718) | | | (87,789) | | | Deferred tax asset (liability), net | $ | (3,644) | | | $ | (50,988) | |
|
| Schedule of Effective Income Tax Rate Reconciliation |
A reconciliation of income tax expense computed at the federal statutory rate of 21% to actual income tax expense at the Company’s effective rate is as follows (in thousands): | | | | | | | | | | | | | | | | | | | Year Ended December 31, | | 2024 | | 2023 | | 2022 | Income tax rate reconciliation | | | | | | | Income tax expense (benefit) at U.S. statutory rate | $ | (52,621) | | | $ | 37,204 | | | $ | (1,040) | | State income taxes | 1,732 | | | 4,150 | | | 530 | | | Officer’s compensation | 350 | | | 518 | | | 740 | | | Equity-based compensation | 595 | | | (932) | | | 712 | | | Contingent consideration | 26 | | | 622 | | | (947) | | | Tax credits | (4,554) | | | (407) | | | (421) | | | Non-U.S. income taxed at different rate than U.S. statutory rate | (15,135) | | | 2,658 | | | (4,274) | | | Non-U.S. indirect tax incentives | 975 | | | (5,035) | | | (4,183) | | | Foreign derived intangible income benefit | — | | | (403) | | | (1,668) | | | Transaction costs | — | | | — | | | 1,628 | | | Non-deductible Goodwill Impairment | 49,560 | | | — | | | — | | | Change in valuation allowance | 7,760 | | | 911 | | | (534) | | | Uncertain tax benefits | 714 | | | — | | | — | | | Nondeductible expenses | 481 | | | 299 | | | 10 | | | Other | (65) | | | 332 | | | 63 | | Total income tax expense (benefit) | $ | (10,182) | | | $ | 39,917 | | | $ | (9,384) | |
|
| Schedule of Unrecognized Tax Benefits Roll Forward |
A reconciliation of the unrecognized tax benefits included within Other long-term liabilities on the consolidated statement of operations is as follows (in thousands): | | | | | | | | | | | | | | | | | | | Year Ended December 31, | | 2024 | | 2023 | | 2022 | | Unrecognized tax benefits – January 1 | $ | — | | | $ | — | | | $ | — | | | Gross increases – tax positions in prior period | 533 | | | — | | | — | | | Gross decreases – tax positions in prior period | — | | | — | | | — | | | Gross increases – tax positions in current period | 181 | | | — | | | — | | | Settlement | — | | | — | | | — | | | Lapse of statute of limitations | — | | | — | | | — | | | Unrecognized tax benefits – December 31 | $ | 714 | | | $ | — | | | $ | — | |
|